The exercise scientist recently shared a video with his tops tips for maximizing chest gains—especially for those who have ...

Vast has started testing a qualification model of its first commercial space station but has pushed back the launch of that ...

Phase transitions, shifts between different states of matter, are widely explored physical phenomena. So far, these ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

What is the moon phase today? Today, Feb. 3, 2025, the moon is 5 days old, in the waxing crescent phase of its lunar cycle. It is 32% illuminated. Moon phases reveal the passage of time in the ...

NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...

At present, flow cytometry is by far the most useful approach for genetic analysis and library-screening purposes (Box 1). Flow cytometers such as the Becton Dickinson FACSAria or DakoCytomation ...

Vast's bold ambition: developing Haven-1, the first commercial space station. Learn about their successful primary structure qualification proof test.

An MTF2-containing subcomplex of Polycomb Repressive Complex 2 promotes cell cycle progression through repression of D-type cyclin expression in certain cellular contexts.